Class: Selective beta-2-Adrenergic Agonists
VA Class: RE102
Chemical Name: (±)-2′-Hydroxy-5′-[(R*)-1-hydroxy-2-[[(R*)-p-methoxy-α-methylphenethyl]amino]ethyl]formanilide fumarate
Molecular Formula: C19H24N2O4)2•C4H4O4
CAS Number: 43229-80-7
Brands: Bevespi Aerosphere (combination)
Warning
Monotherapy with long-acting β2-adrenergic agonists (e.g., formoterol) increases the risk of asthma-related death and may increase the risk of asthma-related hospitalization in children and adolescents. (See Asthma-related Death and Serious Asthma-related Events under Cautions.)
Increased risk of asthma-related death considered class effect of long-acting β2-adrenergic agonists, including formoterol.
Use of formoterol for treatment of asthma without concomitant use of long-term asthma controller therapy (e.g., inhaled corticosteroids) is contraindicated. (See Contraindications under Cautions.)
Introduction
Bronchodilator; a relatively selective, long-acting β2-adrenergic agonist.
Uses for Formoterol
Bronchospasm in Asthma
Formoterol: Used concomitantly with long-term asthma controller therapy (e.g., inhaled corticosteroids) for prevention of bronchospasm in patients with reversible obstructive airway disease (e.g., asthma).
Monotherapy with long-acting β2-adrenergic agonists (e.g., formoterol) increases the risk of asthma-related death and may increase the risk of asthma-related hospitalization in children and adolescents.Use of formoterol alone for treatment of asthma without concomitant use of long-term asthma controller therapy (e.g., inhaled corticosteroids) is contraindicated. (See Asthma-related Death and Serious Asthma-related Events under Cautions.)
Formoterol in fixed combination with budesonide or mometas...
